Cardinal Health (CAH) vs Cellyan Biotechnology (HKPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cardinal Health is the larger company by market cap ($55.33 billion vs $5.0 million), about 11130.8 times the size. Cardinal Health pays a dividend yielding 0.86%, while Cellyan Biotechnology does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAH | HKPD |
|---|---|---|
| Share price | $238.96 | $0.1008 |
| Market cap | $55.33B | $4.97M |
| 1-day change | +2.93% | -2.80% |
| YTD return | +16.28% | — |
| 1-year return | +51.46% | — |
| 5-year return | +392.30% | — |
| P/E ratio (TTM) | 33.05 | — |
| Forward P/E | 17.00 | — |
| EPS (TTM) | $7.23 | $-0.07 |
| Dividend yield | 0.86% | 0.00% |
| Annual dividend | $2.05 | $0.00 |
| Revenue (latest FY) | $254.25B | — |
| Revenue growth (YoY) | +14.23% | — |
| Net income (latest FY) | $1.71B | — |
| Gross margin | 3.84% | — |
| Operating margin | 1.03% | — |
| Net margin | 0.67% | — |
| 52-week high | $258.30 | $1.72 |
| 52-week low | $151.87 | $0.095 |
| Distance from 52-week high | -7.49% | -94.14% |
| Analyst consensus | buy | — |
| Avg. price target upside | +13.13% | — |
| Average volume | 1.89M | 3.78M |
| Shares outstanding | 231.56M | 42.17M |
| Employees | 58,788 | 11 |
| Sector | Health Care | Healthcare |
| Industry | Other Pharmaceuticals | Medical Distribution |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cardinal Health is about 11130.8 times larger than Cellyan Biotechnology by market value ($55.33B vs $4.97M).
- The two companies sit in different sectors: Cardinal Health in Health Care and Cellyan Biotechnology in Healthcare.
About Cardinal Health
CAH stock →Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.
Health Care · Other Pharmaceuticals · 58,788 employees
About Cellyan Biotechnology
HKPD stock →Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Healthcare · Medical Distribution · 11 employees
CAH vs HKPD FAQ
Which is bigger, Cardinal Health or Cellyan Biotechnology?
Cardinal Health (CAH) is larger, with a market capitalization of $55.33B compared with $4.97M for Cellyan Biotechnology (HKPD).
Which pays a higher dividend, Cardinal Health or Cellyan Biotechnology?
Cardinal Health pays a dividend yielding 0.86%, while Cellyan Biotechnology does not currently pay a regular dividend.
Are Cardinal Health and Cellyan Biotechnology in the same industry?
No. Cardinal Health is in the Health Care sector, while Cellyan Biotechnology is in Healthcare.